Clinical trial

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone

NCT01142518

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2005-07-01

PhaseN/A

Study timeline

Study start (unknown)2005-07-01Date precision: month

Registry last updated2014-03-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-Remitting Multiple Sclerosisunresolved

Interventions

Interferon beta 1aDRUG

Sponsors & collaborators

Merck KGaA, Darmstadt, Germanylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01142518 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.